Literature DB >> 11849747

Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma.

Masanobu Nakajima1, Hiroyuki Kuwano, Tatsuya Miyazaki, Norihiro Masuda, Hiroyuki Kato.   

Abstract

The objective of this study was to clarify the clinicopathologic and prognostic significance of heat shock proteins (HSP) 27 and 70 expression in esophageal squamous cell carcinoma (SCC). Immunohistochemical staining for HSPs 27 and 70 was performed on surgical specimens obtained from 62 patients with esophageal SCC. The expression of both HSPs 27 and 70 correlated inversely with depth of invasion (P<0.05) and pathologic stage (P<0.05), and correlated positively with lymphocyte infiltration (P<0.05). Reduction of HSP 70 expression was significantly correlated with poor prognosis (P<0.05). Patients with HSP 27-negative tumors tended to have a poor prognosis compared with patients with HSP 27-positive tumors. The present findings suggest that HSPs 27 and 70 are significant prognostic factors for esophageal SCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849747     DOI: 10.1016/s0304-3835(01)00825-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer.

Authors:  Feng Wang; Peng Zhang; Chenzhang Shi; Yongzhi Yang; Huanlong Qin
Journal:  Med Oncol       Date:  2011-08-23       Impact factor: 3.064

2.  Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.

Authors:  Zhenkun Zhu; Xin Xu; Yanke Yu; Martin Graham; Mark E Prince; Thomas E Carey; Duxin Sun
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

3.  Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma.

Authors:  Xiaofei Chang; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  Int J Oncol       Date:  2011-01-21       Impact factor: 5.650

4.  Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis.

Authors:  J Gong; D Weng; T Eguchi; A Murshid; M Y Sherman; B Song; S K Calderwood
Journal:  Oncogene       Date:  2015-02-09       Impact factor: 9.867

Review 5.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

6.  Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human esophageal squamous cell carcinoma.

Authors:  Xiaoping Wang; Qiaoxia Wang; Huanping Lin
Journal:  Clin Dev Immunol       Date:  2010-03-10

7.  Increased expression of HSP27 inhibits invasion and metastasis in human esophageal squamous cell carcinoma.

Authors:  Lin Xue; Lei Yang; Zhi-an Jin; Fei Gao; Jian-qin Kang; Guang-hui Xu; Bing Liu; Hong Li; Xiao-juan Wang; Li-juan Liu; Biao-luo Wang; Shu-hui Liang; Jie Ding
Journal:  Tumour Biol       Date:  2014-04-20

8.  Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases.

Authors:  Xiao-Dong Zhu; Cheng-Lin Li; Zhen-Wei Lang; George F Gao; Po Tien
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer.

Authors:  Frank Tavassol; Oliver F Starke; Horst Kokemüller; Gerd Wegener; Corinna C M Müller-Tavassol; Nils-Claudius Gellrich; André Eckardt
Journal:  Head Neck Oncol       Date:  2011-02-23

10.  Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.

Authors:  Su-Feng Chen; Shin Nieh; Shu-Wen Jao; Chia-Lin Liu; Chien-Hua Wu; Yun-Ching Chang; Chin-Yuh Yang; Yaoh-Shiang Lin
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.